✦ LIBER ✦

NICE guidance on vemurafenib for treating locally advanced or metastatic BRAF V600 mutation-positive malignant melanoma

✍ Scribed by Kumar Perampaladas; Nicola Hay; Fiona Rinaldi; Janet Robertson; Jane Adam

Book ID: 119609166
Publisher: The Lancet
Year: 2013
Tongue: English
Weight: 50 KB
Volume: 14
Category: Article
ISSN: 1470-2045
DOI: 10.1016/s1470-2045(12)70565-x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Vemurafenib for the Treatment of Locally

Vemurafenib for the Treatment of Locally Advanced or Metastatic BRAF V600 Mutation-Positive Malignant Melanoma: A NICE Single Technology Appraisal

✍ Beale, Sophie; Dickson, Rumona; Bagust, Adrian; Blundell, Michaela; Dundar, Yena 📂 Article 📅 2013 🏛 Springer International Publishing AG 🌐 English ⚖ 282 KB

NICE guidance on ipilimumab for treating

NICE guidance on ipilimumab for treating previously untreated advanced (unresectable or metastatic) melanoma

✍ Hall, Caroline J; Doss, Sally; Robertson, Janet; Adam, Jane 📂 Article 📅 2014 🏛 The Lancet 🌐 English ⚖ 45 KB

NICE guidance on erlotinib for first-lin

NICE guidance on erlotinib for first-line treatment of EGFR-TK mutation-positive advanced or metastatic non-small-cell lung cancer

✍ Bernice Dillon; Bhash Naidoo; Helen Knight; Peter Clark 📂 Article 📅 2012 🏛 The Lancet 🌐 English ⚖ 44 KB